Investor Relations

Investor Relations

Corporate Profile

Novavax, Inc. is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines.

Latest Investor Presentation
(Updated May 13, 2021)
Latest Earnings Presentation
(Updated May 10, 2021)

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.